Full-Time

Senior Quality Assurance Specialist

Supplier Quality

Confirmed live in the last 24 hours

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

501-1,000 employees

Develops RNAi-based therapies for diseases

Compensation Overview

$85k - $115k/yr

Senior, Expert

Fitchburg, WI, USA

All applicants must have authorization to work in the US for a company.

Category
QA & Testing
Quality Assurance
Required Skills
Google Cloud Platform
Requirements
  • BS/BA in an applicable scientific field such as chemistry, biology, or biochemistry is preferred
  • 8 years of quality assurance experience in a biotech or pharmaceutical development, manufacturing, or contract manufacturing organization.
  • Working knowledge of GMP, GCP, and/or GLP regulations as well as ICH and FDA guidance documents.
  • Prior experience with use of an electronic document management system in a regulated environment.
  • Competent knowledge of and ability to use Adobe Acrobat, Microsoft Office programs, DocuSign, and SmartSheet.
  • Excellent interpersonal, verbal, and written communication skills.
  • Ability to consistently communicate with external parties in a professional manner.
  • Ability to follow company procedures, work instructions, and policies.
  • Excellent attention to detail and organizational skills.
  • Ability to work independently with minimal supervision as well as manage priorities within a face paced environment.
Responsibilities
  • Complete requests for supplier documentation in support of supplier maintenance activities.
  • Perform quality agreement lifecycle management, including but not limited to, drafting, editing, reviewing, approving, and ensuring compliance with periodic review cycles.
  • Review, approve, categorize, and maintain supplier documentation, including but not limited to, questionnaires, registration documents, accreditations, certifications, BSE/TSE statements, etc.
  • Collaborate with QA teammates and supplier quality assurance representatives on supplier quality events and non-conformances as outlined in the applicable quality agreements.
  • Capture supplier quality data and generate metrics.
  • Scan and upload documents to the EDMS, properly categorize within the system, and route for verification/approval.
  • Assist with preparation, update, review, and routing of Arrowhead procedural documents.
  • Assist with QA duties as needed.
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing the genes responsible for them. The company uses RNA interference (RNAi), a natural process that reduces the expression of specific genes, to achieve effective gene silencing. This method allows Arrowhead to significantly lower the activity of harmful genes, potentially stopping or reversing diseases like cystic fibrosis and hepatitis B. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, utilizing a wide range of RNA chemistries and efficient delivery methods. Their goal is to meet unmet medical needs by providing new treatment options for genetic disorders, supported by partnerships with larger pharmaceutical companies and a strong pipeline of drug development.

Company Size

501-1,000

Company Stage

IPO

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead's collaboration with Sarepta includes a $500M upfront payment for RNA drug development.
  • Positive Phase 2 data for plozasiran boosts Arrowhead's credibility in treating hypertriglyceridemia.
  • Strategic financing with Sixth Street provides capital to advance Arrowhead's research pipeline.

What critics are saying

  • Increased competition from companies like Alnylam may impact Arrowhead's market share.
  • Potential regulatory scrutiny could delay Arrowhead's clinical trials for RNAi therapies.
  • Reliance on strategic financing may lead to increased debt obligations for Arrowhead.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead uses RNAi to target and silence disease-causing genes effectively.
  • The company has a broad portfolio of RNA chemistries for diverse therapeutic applications.
  • Arrowhead's strategic partnerships enhance its capabilities in developing innovative RNAi therapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave

Company News

BioSpace
Apr 15th, 2025
Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer

Mr. Apel joins the company from Walgreens Boots Alliance, where he served as Global Head of Financial Planning and Analysis from 2019 through 2024.

PharmaData
Mar 1st, 2025
Arrowhead Pharmaceuticals Launches FCS Patient Resources on Rare Disease Day

Arrowhead Pharmaceuticals launches FCS patient resources on Rare Disease Day.

Business Wire
Feb 28th, 2025
Arrowhead Pharmaceuticals Launches on Rare Disease Day New Patient-Centric Resources for Those Affected by Familial Chylomicronemia Syndrome (FCS)

New Patient Resource Hub: Arrowhead expands its We'll Get There Soon campaign with the launch of a dedicated patient website, providing education, tools, and support for those living with FCS and extremely high triglycerides

World Pharmaceuticals
Nov 29th, 2024
Dev4All and Pharmaseed enter commercial partnership for preclinical R&D

Recently, Arrowhead Pharmaceuticals and Sarepta Therapeutics signed a global licensing and collaboration agreement to develop clinical and preclinical programmes.

BioSpace
Nov 26th, 2024
Sarepta Aims Up to $10B at Arrowhead to Diversify Pipeline With RNA Drugs

Sarepta Therapeutics is putting massive biobucks on the line to work on RNA drugs with Arrowhead, paying out $500 million upfront to find new treatments for rare genetic diseases of the muscle, central nervous system and lung.